drugset

drugset / Trial / NCT00103922

Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)

NCT00103922 ↗

Phase 3 Completed 600 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindTreatment

Summary

This study was designed to determine if the investigational drug is effective and safe in individuals with COPD (chronic pulmonary disease)

Timeline

Start: 2004-11
Primary completion: 2007-01
Completion: 2007-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	cilomilast	Small molecule	15 mg	—

Indications